

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular filtration (GO:0003094) | 5.41665048 |
| 2 | renal filtration (GO:0097205) | 5.03154500 |
| 3 | cell migration involved in heart development (GO:0060973) | 4.96118293 |
| 4 | hemidesmosome assembly (GO:0031581) | 4.95353547 |
| 5 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.74945046 |
| 6 | mesenchymal cell development (GO:0014031) | 4.53740085 |
| 7 | lung epithelium development (GO:0060428) | 4.52179739 |
| 8 | atrioventricular valve morphogenesis (GO:0003181) | 4.48632174 |
| 9 | glomerular basement membrane development (GO:0032836) | 4.46498643 |
| 10 | lateral sprouting from an epithelium (GO:0060601) | 4.42245626 |
| 11 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.13800053 |
| 12 | axon extension involved in axon guidance (GO:0048846) | 4.13800053 |
| 13 | cilium movement (GO:0003341) | 3.98094960 |
| 14 | potassium ion import (GO:0010107) | 3.96915447 |
| 15 | limb bud formation (GO:0060174) | 3.90058384 |
| 16 | Notch signaling involved in heart development (GO:0061314) | 3.89497808 |
| 17 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.77822088 |
| 18 | relaxation of smooth muscle (GO:0044557) | 3.76756287 |
| 19 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.76192451 |
| 20 | positive regulation of fatty acid oxidation (GO:0046321) | 3.73651289 |
| 21 | kidney mesenchyme development (GO:0072074) | 3.69485244 |
| 22 | regulation of sequestering of triglyceride (GO:0010889) | 3.68569313 |
| 23 | brown fat cell differentiation (GO:0050873) | 3.68310924 |
| 24 | dermatan sulfate biosynthetic process (GO:0030208) | 3.67771622 |
| 25 | stem cell development (GO:0048864) | 3.64376411 |
| 26 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.61799659 |
| 27 | lymph vessel development (GO:0001945) | 3.55979405 |
| 28 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.54577147 |
| 29 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.53849016 |
| 30 | sodium ion export (GO:0071436) | 3.53354926 |
| 31 | keratan sulfate catabolic process (GO:0042340) | 3.52174467 |
| 32 | cGMP-mediated signaling (GO:0019934) | 3.50810231 |
| 33 | neural crest cell development (GO:0014032) | 3.46632814 |
| 34 | positive regulation of glomerulus development (GO:0090193) | 3.45121937 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.39611041 |
| 36 | dermatan sulfate metabolic process (GO:0030205) | 3.37699415 |
| 37 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.36861930 |
| 38 | glomerular epithelial cell development (GO:0072310) | 3.33225211 |
| 39 | lung lobe morphogenesis (GO:0060463) | 3.29882986 |
| 40 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.29256028 |
| 41 | metanephric mesenchyme development (GO:0072075) | 3.25841839 |
| 42 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.24955739 |
| 43 | desmosome organization (GO:0002934) | 3.23119736 |
| 44 | ventricular system development (GO:0021591) | 3.23023996 |
| 45 | white fat cell differentiation (GO:0050872) | 3.19245926 |
| 46 | glomerulus development (GO:0032835) | 3.18473527 |
| 47 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.17420334 |
| 48 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.17241488 |
| 49 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.15916821 |
| 50 | response to gravity (GO:0009629) | 3.15861660 |
| 51 | aorta morphogenesis (GO:0035909) | 3.14169664 |
| 52 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.14156913 |
| 53 | endocardial cushion morphogenesis (GO:0003203) | 3.13180193 |
| 54 | regulation of fatty acid oxidation (GO:0046320) | 3.12570194 |
| 55 | basement membrane organization (GO:0071711) | 3.11176092 |
| 56 | negative regulation of cartilage development (GO:0061037) | 3.10671281 |
| 57 | establishment of planar polarity (GO:0001736) | 3.08963368 |
| 58 | establishment of tissue polarity (GO:0007164) | 3.08963368 |
| 59 | one-carbon compound transport (GO:0019755) | 3.08852748 |
| 60 | lung-associated mesenchyme development (GO:0060484) | 3.08773005 |
| 61 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.05079853 |
| 62 | ventricular septum morphogenesis (GO:0060412) | 3.04148197 |
| 63 | astrocyte differentiation (GO:0048708) | 3.00970165 |
| 64 | positive regulation of odontogenesis (GO:0042482) | 2.99848531 |
| 65 | heart valve formation (GO:0003188) | 2.99631292 |
| 66 | protein heterotrimerization (GO:0070208) | 2.98395451 |
| 67 | nephron epithelium development (GO:0072009) | 2.97543110 |
| 68 | cell proliferation involved in metanephros development (GO:0072203) | 2.95248889 |
| 69 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.93819584 |
| 70 | non-canonical Wnt signaling pathway (GO:0035567) | 2.90369790 |
| 71 | endothelium development (GO:0003158) | 2.89943949 |
| 72 | cellular potassium ion homeostasis (GO:0030007) | 2.89682339 |
| 73 | negative regulation of axon guidance (GO:1902668) | 2.89265228 |
| 74 | nephron tubule development (GO:0072080) | 2.88380009 |
| 75 | response to parathyroid hormone (GO:0071107) | 2.84667839 |
| 76 | cell proliferation involved in kidney development (GO:0072111) | 2.82973612 |
| 77 | positive regulation of gastrulation (GO:2000543) | 2.81231404 |
| 78 | carnitine shuttle (GO:0006853) | 2.80162973 |
| 79 | response to dietary excess (GO:0002021) | 2.78925331 |
| 80 | mesenchyme morphogenesis (GO:0072132) | 2.78826095 |
| 81 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.77116552 |
| 82 | biotin metabolic process (GO:0006768) | 2.76402845 |
| 83 | regulation of glomerulus development (GO:0090192) | 2.75984731 |
| 84 | negative regulation of catenin import into nucleus (GO:0035414) | 2.75813256 |
| 85 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.74904519 |
| 86 | fatty acid transmembrane transport (GO:1902001) | 2.73898762 |
| 87 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.73390657 |
| 88 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.72581568 |
| 89 | enteric nervous system development (GO:0048484) | 2.72325892 |
| 90 | tonic smooth muscle contraction (GO:0014820) | 2.72278878 |
| 91 | cGMP biosynthetic process (GO:0006182) | 2.68922770 |
| 92 | muscle cell proliferation (GO:0033002) | 2.66114082 |
| 93 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.62913526 |
| 94 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.61545282 |
| 95 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.61423619 |
| 96 | low-density lipoprotein particle clearance (GO:0034383) | 2.61010172 |
| 97 | left/right axis specification (GO:0070986) | 2.60884940 |
| 98 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.60509706 |
| 99 | establishment of nucleus localization (GO:0040023) | 2.60404610 |
| 100 | mesenchymal cell proliferation (GO:0010463) | 2.60116913 |
| 101 | negative regulation of vascular permeability (GO:0043116) | 2.58917141 |
| 102 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.57993676 |
| 103 | positive regulation of embryonic development (GO:0040019) | 2.57145968 |
| 104 | coronary vasculature morphogenesis (GO:0060977) | 2.56050920 |
| 105 | regulation of phospholipase A2 activity (GO:0032429) | 2.55682518 |
| 106 | epithelial cilium movement (GO:0003351) | 2.54504585 |
| 107 | cGMP metabolic process (GO:0046068) | 2.53891209 |
| 108 | cell-substrate junction assembly (GO:0007044) | 2.52961816 |
| 109 | hair follicle development (GO:0001942) | 2.52812142 |
| 110 | glutamate secretion (GO:0014047) | 2.52419269 |
| 111 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.52334506 |
| 112 | negative regulation of humoral immune response (GO:0002921) | 2.52117352 |
| 113 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.51709906 |
| 114 | extracellular fibril organization (GO:0043206) | 2.51493083 |
| 115 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.51434931 |
| 116 | embryonic skeletal system development (GO:0048706) | 2.51181113 |
| 117 | renal tubule development (GO:0061326) | 2.50490558 |
| 118 | myelination in peripheral nervous system (GO:0022011) | 2.50313157 |
| 119 | peripheral nervous system axon ensheathment (GO:0032292) | 2.50313157 |
| 120 | heart valve morphogenesis (GO:0003179) | 2.49840104 |
| 121 | artery smooth muscle contraction (GO:0014824) | 2.48945835 |
| 122 | chondrocyte development (GO:0002063) | 2.48871228 |
| 123 | smooth muscle tissue development (GO:0048745) | 2.48279636 |
| 124 | barbed-end actin filament capping (GO:0051016) | 2.47849923 |
| 125 | establishment of apical/basal cell polarity (GO:0035089) | 2.47424715 |
| 126 | negative regulation of protein autophosphorylation (GO:0031953) | 2.47355189 |
| 127 | negative chemotaxis (GO:0050919) | 2.46836788 |
| 128 | triglyceride catabolic process (GO:0019433) | 2.46097277 |
| 129 | collagen fibril organization (GO:0030199) | 2.45776787 |
| 130 | cardiac muscle cell proliferation (GO:0060038) | 2.45580012 |
| 131 | cardiac ventricle morphogenesis (GO:0003208) | 2.44358359 |
| 132 | establishment of skin barrier (GO:0061436) | 2.44158042 |
| 133 | regulation of axon guidance (GO:1902667) | 2.44009243 |
| 134 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.43806592 |
| 135 | fatty acid beta-oxidation (GO:0006635) | 2.43268986 |
| 136 | positive regulation of catenin import into nucleus (GO:0035413) | 2.42812824 |
| 137 | axonemal dynein complex assembly (GO:0070286) | 2.42648318 |
| 138 | convergent extension (GO:0060026) | 2.42551718 |
| 139 | keratinization (GO:0031424) | 2.42482692 |
| 140 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.42383983 |
| 141 | cardiac right ventricle morphogenesis (GO:0003215) | 2.42040286 |
| 142 | negative regulation of muscle contraction (GO:0045932) | 2.41867297 |
| 143 | cell communication by electrical coupling (GO:0010644) | 2.41168329 |
| 144 | carnitine transmembrane transport (GO:1902603) | 2.40532649 |
| 145 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.39671043 |
| 146 | chondrocyte proliferation (GO:0035988) | 2.38935561 |
| 147 | cell volume homeostasis (GO:0006884) | 2.38368754 |
| 148 | heart trabecula formation (GO:0060347) | 2.37095174 |
| 149 | organ formation (GO:0048645) | 2.36975994 |
| 150 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.36852353 |
| 151 | artery morphogenesis (GO:0048844) | 2.36582774 |
| 152 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.36209340 |
| 153 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.35555101 |
| 154 | activation of protein kinase A activity (GO:0034199) | 2.35210010 |
| 155 | striated muscle cell proliferation (GO:0014855) | 2.34985151 |
| 156 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.34711517 |
| 157 | relaxation of muscle (GO:0090075) | 2.34619266 |
| 158 | cardiac myofibril assembly (GO:0055003) | 2.34572967 |
| 159 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.33467430 |
| 160 | notochord development (GO:0030903) | 2.33450941 |
| 161 | adherens junction assembly (GO:0034333) | 2.33088131 |
| 162 | patterning of blood vessels (GO:0001569) | 2.32985350 |
| 163 | chondroitin sulfate catabolic process (GO:0030207) | 2.32750543 |
| 164 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.32692874 |
| 165 | innervation (GO:0060384) | 2.31962635 |
| 166 | cochlea morphogenesis (GO:0090103) | 2.31483851 |
| 167 | angiogenesis involved in wound healing (GO:0060055) | 2.31272918 |
| 168 | retinal ganglion cell axon guidance (GO:0031290) | 2.30980450 |
| 169 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.30544993 |
| 170 | proline transport (GO:0015824) | 2.29748096 |
| 171 | somite development (GO:0061053) | 2.29719039 |
| 172 | cardiac chamber morphogenesis (GO:0003206) | 2.29695474 |
| 173 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.29675274 |
| 174 | response to leptin (GO:0044321) | 2.29514532 |
| 175 | positive regulation of BMP signaling pathway (GO:0030513) | 2.29408470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.21849586 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.01680643 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.78115082 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.49352877 |
| 5 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.40600567 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.31039617 |
| 7 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.23701544 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22058024 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22058024 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.16300258 |
| 11 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.14510252 |
| 12 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.14384727 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11775343 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05561294 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02311597 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96630199 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.93347589 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.92678389 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89907869 |
| 20 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.89723035 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85376762 |
| 22 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.85197953 |
| 23 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.83482718 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.80444985 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73899987 |
| 26 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.71445489 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68610642 |
| 28 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.68296781 |
| 29 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.66952788 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.66167671 |
| 31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.65412232 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65141611 |
| 33 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59614145 |
| 34 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.58613852 |
| 35 | RXR_22108803_ChIP-Seq_LS180_Human | 1.56473260 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.56216856 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54064982 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53932112 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.50889043 |
| 40 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.44743574 |
| 41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42570931 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40888959 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40591750 |
| 44 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.37764194 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37275127 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36848552 |
| 47 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36546149 |
| 48 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30509299 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29034649 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28732652 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25309571 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24785473 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23802847 |
| 54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22579146 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22551476 |
| 56 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22264804 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21991115 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21383100 |
| 59 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21204541 |
| 60 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19963657 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19061265 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18148335 |
| 63 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17065334 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16754086 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16754086 |
| 66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15467989 |
| 67 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14863470 |
| 68 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14427441 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.13179440 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12632585 |
| 71 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12501063 |
| 72 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11756004 |
| 73 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.11741647 |
| 74 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.10367891 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10329025 |
| 76 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10329025 |
| 77 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.09405083 |
| 78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09137700 |
| 79 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.08722872 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08606737 |
| 81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.07572102 |
| 82 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07106876 |
| 83 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07049218 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06646917 |
| 85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06624907 |
| 86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06390091 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04809380 |
| 88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.03171367 |
| 89 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03038668 |
| 90 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03012308 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01442897 |
| 92 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.00748384 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00377157 |
| 94 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98882402 |
| 95 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98065602 |
| 96 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97686373 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97673057 |
| 98 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97396432 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96447316 |
| 100 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96407345 |
| 101 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96298532 |
| 102 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96147128 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95968517 |
| 104 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95956454 |
| 105 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.95777823 |
| 106 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95437921 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95411005 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95356882 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95282982 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95254402 |
| 111 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95207506 |
| 112 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94880779 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92895754 |
| 114 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92076592 |
| 115 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91707664 |
| 116 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91602032 |
| 117 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.91346282 |
| 118 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.89533530 |
| 119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88668531 |
| 120 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.88646866 |
| 121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88303261 |
| 122 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86965175 |
| 123 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85625377 |
| 124 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.85211104 |
| 125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.85176069 |
| 126 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.84366465 |
| 127 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.82735428 |
| 128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82597827 |
| 129 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.82216685 |
| 130 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.79273724 |
| 131 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.78879389 |
| 132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78871319 |
| 133 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.77706260 |
| 134 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77329386 |
| 135 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76891561 |
| 136 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75463194 |
| 137 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74987620 |
| 138 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.74488591 |
| 139 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.74329933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 3.59024449 |
| 2 | MP0005275_abnormal_skin_tensile | 3.12910622 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.08014827 |
| 4 | MP0002254_reproductive_system_inflammat | 2.96386498 |
| 5 | MP0004272_abnormal_basement_membrane | 2.95760419 |
| 6 | MP0003283_abnormal_digestive_organ | 2.55770911 |
| 7 | MP0005666_abnormal_adipose_tissue | 2.52382943 |
| 8 | MP0002249_abnormal_larynx_morphology | 2.48515819 |
| 9 | MP0004185_abnormal_adipocyte_glucose | 2.38899898 |
| 10 | MP0000467_abnormal_esophagus_morphology | 2.38575297 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.28326872 |
| 12 | MP0000537_abnormal_urethra_morphology | 2.24200306 |
| 13 | MP0009053_abnormal_anal_canal | 2.16469019 |
| 14 | MP0005503_abnormal_tendon_morphology | 2.13234119 |
| 15 | MP0002282_abnormal_trachea_morphology | 2.09535852 |
| 16 | MP0004130_abnormal_muscle_cell | 2.09156688 |
| 17 | MP0010368_abnormal_lymphatic_system | 2.07653683 |
| 18 | MP0010030_abnormal_orbit_morphology | 2.04484099 |
| 19 | MP0009384_cardiac_valve_regurgitation | 2.00851179 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.91495186 |
| 21 | MP0005623_abnormal_meninges_morphology | 1.90100390 |
| 22 | MP0000566_synostosis | 1.87980772 |
| 23 | MP0002060_abnormal_skin_morphology | 1.85468934 |
| 24 | MP0000013_abnormal_adipose_tissue | 1.83731805 |
| 25 | MP0000767_abnormal_smooth_muscle | 1.83331440 |
| 26 | MP0009250_abnormal_appendicular_skeleto | 1.81731394 |
| 27 | MP0000383_abnormal_hair_follicle | 1.80934694 |
| 28 | MP0005375_adipose_tissue_phenotype | 1.80392077 |
| 29 | MP0002009_preneoplasia | 1.79736275 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.78823583 |
| 31 | MP0000762_abnormal_tongue_morphology | 1.78223815 |
| 32 | MP0002234_abnormal_pharynx_morphology | 1.77603367 |
| 33 | MP0003941_abnormal_skin_development | 1.76565310 |
| 34 | MP0002796_impaired_skin_barrier | 1.74084602 |
| 35 | MP0001346_abnormal_lacrimal_gland | 1.73910801 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.72803900 |
| 37 | MP0005595_abnormal_vascular_smooth | 1.63947562 |
| 38 | MP0004270_analgesia | 1.62262963 |
| 39 | MP0005257_abnormal_intraocular_pressure | 1.58790930 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.58399366 |
| 41 | MP0008004_abnormal_stomach_pH | 1.57703588 |
| 42 | MP0002971_abnormal_brown_adipose | 1.55139059 |
| 43 | MP0001299_abnormal_eye_distance/ | 1.50701568 |
| 44 | MP0000049_abnormal_middle_ear | 1.45955122 |
| 45 | MP0005508_abnormal_skeleton_morphology | 1.45380636 |
| 46 | MP0002102_abnormal_ear_morphology | 1.42299900 |
| 47 | MP0010678_abnormal_skin_adnexa | 1.40650704 |
| 48 | MP0000003_abnormal_adipose_tissue | 1.39735450 |
| 49 | MP0003942_abnormal_urinary_system | 1.37275910 |
| 50 | MP0003938_abnormal_ear_development | 1.36435097 |
| 51 | MP0001879_abnormal_lymphatic_vessel | 1.35763366 |
| 52 | MP0003279_aneurysm | 1.34493369 |
| 53 | MP0002108_abnormal_muscle_morphology | 1.32955340 |
| 54 | MP0002233_abnormal_nose_morphology | 1.31627588 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.24731376 |
| 56 | MP0003635_abnormal_synaptic_transmissio | 1.24051509 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.23149162 |
| 58 | MP0003011_delayed_dark_adaptation | 1.23122511 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.20180811 |
| 60 | MP0001542_abnormal_bone_strength | 1.19739504 |
| 61 | MP0000163_abnormal_cartilage_morphology | 1.19473416 |
| 62 | MP0003646_muscle_fatigue | 1.18823157 |
| 63 | MP0002896_abnormal_bone_mineralization | 1.17594975 |
| 64 | MP0000462_abnormal_digestive_system | 1.15757444 |
| 65 | MP0002933_joint_inflammation | 1.14774585 |
| 66 | MP0000647_abnormal_sebaceous_gland | 1.14401654 |
| 67 | MP0009115_abnormal_fat_cell | 1.13739236 |
| 68 | MP0000579_abnormal_nail_morphology | 1.13643665 |
| 69 | MP0003136_yellow_coat_color | 1.12200498 |
| 70 | MP0000428_abnormal_craniofacial_morphol | 1.10492111 |
| 71 | MP0004215_abnormal_myocardial_fiber | 1.10123772 |
| 72 | MP0004858_abnormal_nervous_system | 1.09841041 |
| 73 | MP0003091_abnormal_cell_migration | 1.07312005 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 1.06403787 |
| 75 | MP0003880_abnormal_central_pattern | 1.06060396 |
| 76 | MP0004133_heterotaxia | 1.04740139 |
| 77 | MP0001340_abnormal_eyelid_morphology | 1.04300540 |
| 78 | MP0003937_abnormal_limbs/digits/tail_de | 1.03945986 |
| 79 | MP0005164_abnormal_response_to | 1.03799412 |
| 80 | MP0002098_abnormal_vibrissa_morphology | 1.03681358 |
| 81 | MP0001958_emphysema | 1.03585908 |
| 82 | MP0003755_abnormal_palate_morphology | 1.03181928 |
| 83 | MP0003385_abnormal_body_wall | 1.02242575 |
| 84 | MP0010771_integument_phenotype | 1.01761462 |
| 85 | MP0000534_abnormal_ureter_morphology | 1.00692912 |
| 86 | MP0002116_abnormal_craniofacial_bone | 1.00400642 |
| 87 | MP0004084_abnormal_cardiac_muscle | 0.99545642 |
| 88 | MP0005409_darkened_coat_color | 0.98157189 |
| 89 | MP0002734_abnormal_mechanical_nocicepti | 0.97680571 |
| 90 | MP0005187_abnormal_penis_morphology | 0.96527448 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.94556429 |
| 92 | MP0001501_abnormal_sleep_pattern | 0.94131621 |
| 93 | MP0002932_abnormal_joint_morphology | 0.93023956 |
| 94 | MP0002972_abnormal_cardiac_muscle | 0.91137806 |
| 95 | MP0008569_lethality_at_weaning | 0.90109246 |
| 96 | MP0002063_abnormal_learning/memory/cond | 0.89262204 |
| 97 | MP0002111_abnormal_tail_morphology | 0.88475302 |
| 98 | MP0002128_abnormal_blood_circulation | 0.86763502 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.86209626 |
| 100 | MP0002127_abnormal_cardiovascular_syste | 0.85985788 |
| 101 | MP0001614_abnormal_blood_vessel | 0.85167058 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.85158883 |
| 103 | MP0003690_abnormal_glial_cell | 0.85005096 |
| 104 | MP0006138_congestive_heart_failure | 0.84830686 |
| 105 | MP0001216_abnormal_epidermal_layer | 0.83527164 |
| 106 | MP0003959_abnormal_lean_body | 0.83430355 |
| 107 | MP0002115_abnormal_skeleton_extremities | 0.82914972 |
| 108 | MP0010329_abnormal_lipoprotein_level | 0.82657583 |
| 109 | MP0009745_abnormal_behavioral_response | 0.81681981 |
| 110 | MP0005620_abnormal_muscle_contractility | 0.81038347 |
| 111 | MP0000343_altered_response_to | 0.80994823 |
| 112 | MP0005023_abnormal_wound_healing | 0.80899657 |
| 113 | MP0005165_increased_susceptibility_to | 0.80515625 |
| 114 | MP0005390_skeleton_phenotype | 0.79977694 |
| 115 | MP0000778_abnormal_nervous_system | 0.79780921 |
| 116 | MP0003075_altered_response_to | 0.79170614 |
| 117 | MP0001270_distended_abdomen | 0.78871924 |
| 118 | MP0005385_cardiovascular_system_phenoty | 0.78817074 |
| 119 | MP0001544_abnormal_cardiovascular_syste | 0.78817074 |
| 120 | MP0004087_abnormal_muscle_fiber | 0.78277689 |
| 121 | MP0009379_abnormal_foot_pigmentation | 0.77364531 |
| 122 | MP0002572_abnormal_emotion/affect_behav | 0.77016412 |
| 123 | MP0003879_abnormal_hair_cell | 0.75986057 |
| 124 | MP0000432_abnormal_head_morphology | 0.75804260 |
| 125 | MP0000751_myopathy | 0.75614116 |
| 126 | MP0002272_abnormal_nervous_system | 0.74399298 |
| 127 | MP0002109_abnormal_limb_morphology | 0.73695703 |
| 128 | MP0005535_abnormal_body_temperature | 0.73609457 |
| 129 | MP0001851_eye_inflammation | 0.73545456 |
| 130 | MP0000733_abnormal_muscle_development | 0.73352543 |
| 131 | MP0000613_abnormal_salivary_gland | 0.72791465 |
| 132 | MP0002064_seizures | 0.72607729 |
| 133 | MP0010630_abnormal_cardiac_muscle | 0.72134800 |
| 134 | MP0003828_pulmonary_edema | 0.71354713 |
| 135 | MP0004885_abnormal_endolymph | 0.71327736 |
| 136 | MP0000759_abnormal_skeletal_muscle | 0.71160567 |
| 137 | MP0004145_abnormal_muscle_electrophysio | 0.70730528 |
| 138 | MP0004233_abnormal_muscle_weight | 0.70272272 |
| 139 | MP0000249_abnormal_blood_vessel | 0.68750571 |
| 140 | MP0001664_abnormal_digestion | 0.67937707 |
| 141 | MP0001177_atelectasis | 0.67717401 |
| 142 | MP0005388_respiratory_system_phenotype | 0.67716610 |
| 143 | MP0002133_abnormal_respiratory_system | 0.67716610 |
| 144 | MP0008961_abnormal_basal_metabolism | 0.67700353 |
| 145 | MP0000026_abnormal_inner_ear | 0.67455115 |
| 146 | MP0000427_abnormal_hair_cycle | 0.66804137 |
| 147 | MP0002909_abnormal_adrenal_gland | 0.66535686 |
| 148 | MP0001486_abnormal_startle_reflex | 0.66491471 |
| 149 | MP0004036_abnormal_muscle_relaxation | 0.66478793 |
| 150 | MP0003935_abnormal_craniofacial_develop | 0.65995231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.17011010 |
| 2 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.29994663 |
| 3 | Aortic aneurysm (HP:0004942) | 4.00314990 |
| 4 | Axonal loss (HP:0003447) | 3.81592048 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.76398780 |
| 6 | Acanthosis nigricans (HP:0000956) | 3.56654673 |
| 7 | Papilledema (HP:0001085) | 3.55832375 |
| 8 | Protrusio acetabuli (HP:0003179) | 3.51696384 |
| 9 | Bronchomalacia (HP:0002780) | 3.46230976 |
| 10 | Rhinitis (HP:0012384) | 3.41406099 |
| 11 | Atrophic scars (HP:0001075) | 3.38732916 |
| 12 | Shallow orbits (HP:0000586) | 3.37867184 |
| 13 | Broad metatarsal (HP:0001783) | 3.35604729 |
| 14 | Increased connective tissue (HP:0009025) | 3.29392911 |
| 15 | Premature rupture of membranes (HP:0001788) | 3.22777708 |
| 16 | Metaphyseal dysplasia (HP:0100255) | 3.20503684 |
| 17 | Abnormal ciliary motility (HP:0012262) | 3.12877648 |
| 18 | Chronic bronchitis (HP:0004469) | 3.10233475 |
| 19 | Synostosis involving the elbow (HP:0003938) | 3.09653008 |
| 20 | Humeroradial synostosis (HP:0003041) | 3.09653008 |
| 21 | Aplasia involving bones of the extremities (HP:0009825) | 3.07274595 |
| 22 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.07274595 |
| 23 | Aplasia of the phalanges of the hand (HP:0009802) | 3.07274595 |
| 24 | Fragile nails (HP:0001808) | 3.07245244 |
| 25 | Fragile skin (HP:0001030) | 3.02428354 |
| 26 | Short hallux (HP:0010109) | 2.99135162 |
| 27 | Vascular tortuosity (HP:0004948) | 2.95044900 |
| 28 | Abnormality of dentin (HP:0010299) | 2.94948728 |
| 29 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.93232495 |
| 30 | Arterial tortuosity (HP:0005116) | 2.92732480 |
| 31 | Hypercortisolism (HP:0001578) | 2.89130502 |
| 32 | Milia (HP:0001056) | 2.88004265 |
| 33 | Bladder diverticulum (HP:0000015) | 2.83546579 |
| 34 | Spinal rigidity (HP:0003306) | 2.75239937 |
| 35 | Ankle contracture (HP:0006466) | 2.74710957 |
| 36 | Concave nail (HP:0001598) | 2.71150772 |
| 37 | Pulmonary artery stenosis (HP:0004415) | 2.69720894 |
| 38 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.69196286 |
| 39 | Hemiplegia (HP:0002301) | 2.68549385 |
| 40 | Vertebral arch anomaly (HP:0008438) | 2.66513389 |
| 41 | Tarsal synostosis (HP:0008368) | 2.64735267 |
| 42 | Abnormality of the vertebral endplates (HP:0005106) | 2.64269425 |
| 43 | Neonatal short-limb short stature (HP:0008921) | 2.63976418 |
| 44 | Hypercalcemia (HP:0003072) | 2.62959909 |
| 45 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.62381767 |
| 46 | Ectopia lentis (HP:0001083) | 2.59962304 |
| 47 | Ridged nail (HP:0001807) | 2.56988398 |
| 48 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.56203283 |
| 49 | Follicular hyperkeratosis (HP:0007502) | 2.55177342 |
| 50 | Maternal diabetes (HP:0009800) | 2.53196287 |
| 51 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.48384800 |
| 52 | Wormian bones (HP:0002645) | 2.45301304 |
| 53 | Synostosis involving bones of the feet (HP:0009140) | 2.44620959 |
| 54 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.44620959 |
| 55 | Right ventricular cardiomyopathy (HP:0011663) | 2.41811223 |
| 56 | Back pain (HP:0003418) | 2.38014956 |
| 57 | Difficulty running (HP:0009046) | 2.37677988 |
| 58 | Onycholysis (HP:0001806) | 2.35370893 |
| 59 | Venous insufficiency (HP:0005293) | 2.29144286 |
| 60 | Ulnar claw (HP:0001178) | 2.28415254 |
| 61 | Mitral valve prolapse (HP:0001634) | 2.28414135 |
| 62 | Infantile muscular hypotonia (HP:0008947) | 2.28096913 |
| 63 | Cranial hyperostosis (HP:0004437) | 2.27210132 |
| 64 | Turricephaly (HP:0000262) | 2.25450566 |
| 65 | Genu recurvatum (HP:0002816) | 2.23937871 |
| 66 | Sudden death (HP:0001699) | 2.23821901 |
| 67 | Mild short stature (HP:0003502) | 2.23420151 |
| 68 | Craniofacial hyperostosis (HP:0004493) | 2.23216319 |
| 69 | Mesangial abnormality (HP:0001966) | 2.23161551 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.23023884 |
| 71 | Morphological abnormality of the middle ear (HP:0008609) | 2.22999025 |
| 72 | Type 1 muscle fiber predominance (HP:0003803) | 2.21999115 |
| 73 | Hyperglycinuria (HP:0003108) | 2.20158799 |
| 74 | Hyperthyroidism (HP:0000836) | 2.19485370 |
| 75 | Abnormality of the ischium (HP:0003174) | 2.19363110 |
| 76 | Fibular hypoplasia (HP:0003038) | 2.16707247 |
| 77 | Tubular atrophy (HP:0000092) | 2.15811824 |
| 78 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.13788418 |
| 79 | Absent/shortened dynein arms (HP:0200106) | 2.13788418 |
| 80 | Aplasia cutis congenita (HP:0001057) | 2.12223886 |
| 81 | Myokymia (HP:0002411) | 2.11023395 |
| 82 | Broad distal phalanx of finger (HP:0009836) | 2.10618559 |
| 83 | Anterior segment dysgenesis (HP:0007700) | 2.10120167 |
| 84 | Broad ribs (HP:0000885) | 2.09999404 |
| 85 | Spinal cord compression (HP:0002176) | 2.08192745 |
| 86 | Abnormality of the frontal sinuses (HP:0002687) | 2.07016129 |
| 87 | Anophthalmia (HP:0000528) | 2.06458659 |
| 88 | Prenatal maternal abnormality (HP:0002686) | 2.06380062 |
| 89 | Depressed nasal tip (HP:0000437) | 2.04683401 |
| 90 | Hypoplastic ischia (HP:0003175) | 2.04025117 |
| 91 | Hemiparesis (HP:0001269) | 2.03615782 |
| 92 | Aortic dissection (HP:0002647) | 2.01929318 |
| 93 | Hypotrichosis (HP:0001006) | 2.01587463 |
| 94 | Obstructive sleep apnea (HP:0002870) | 2.00049531 |
| 95 | Abnormal hemoglobin (HP:0011902) | 1.99616244 |
| 96 | Oligomenorrhea (HP:0000876) | 1.97774929 |
| 97 | Median cleft lip (HP:0000161) | 1.97343761 |
| 98 | Mitral stenosis (HP:0001718) | 1.96913825 |
| 99 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.96835975 |
| 100 | Dilatation of the ascending aorta (HP:0005111) | 1.96564410 |
| 101 | Soft skin (HP:0000977) | 1.94827035 |
| 102 | Stroke (HP:0001297) | 1.93854491 |
| 103 | Blue sclerae (HP:0000592) | 1.93448629 |
| 104 | Bell-shaped thorax (HP:0001591) | 1.92573389 |
| 105 | Amblyopia (HP:0000646) | 1.92461618 |
| 106 | Ventricular tachycardia (HP:0004756) | 1.92164919 |
| 107 | Abnormality of the anterior chamber (HP:0000593) | 1.91630691 |
| 108 | Plantar hyperkeratosis (HP:0007556) | 1.90898170 |
| 109 | Preaxial foot polydactyly (HP:0001841) | 1.90560595 |
| 110 | Abnormality of molar (HP:0011077) | 1.90462283 |
| 111 | Abnormality of molar morphology (HP:0011070) | 1.90462283 |
| 112 | Hydroxyprolinuria (HP:0003080) | 1.90374175 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 1.90374175 |
| 114 | Osteoarthritis (HP:0002758) | 1.90179059 |
| 115 | Wide anterior fontanel (HP:0000260) | 1.89388227 |
| 116 | Striae distensae (HP:0001065) | 1.88437609 |
| 117 | Alopecia of scalp (HP:0002293) | 1.88094031 |
| 118 | Action tremor (HP:0002345) | 1.87273616 |
| 119 | Hypertriglyceridemia (HP:0002155) | 1.87045605 |
| 120 | Overgrowth (HP:0001548) | 1.86818197 |
| 121 | Conjunctival hamartoma (HP:0100780) | 1.86663049 |
| 122 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86559037 |
| 123 | Hypophosphatemic rickets (HP:0004912) | 1.86338317 |
| 124 | Coronal craniosynostosis (HP:0004440) | 1.85910151 |
| 125 | Abnormality of Sharpey fibers (HP:0100685) | 1.84684024 |
| 126 | Hypodontia (HP:0000668) | 1.84422914 |
| 127 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.83327829 |
| 128 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.83327829 |
| 129 | Metaphyseal cupping (HP:0003021) | 1.81900472 |
| 130 | Spondylolisthesis (HP:0003302) | 1.81648522 |
| 131 | Bilateral microphthalmos (HP:0007633) | 1.80620010 |
| 132 | Pterygium (HP:0001059) | 1.80340226 |
| 133 | Supraventricular arrhythmia (HP:0005115) | 1.79885446 |
| 134 | Distal lower limb muscle weakness (HP:0009053) | 1.79279620 |
| 135 | Complement deficiency (HP:0004431) | 1.78588216 |
| 136 | Myoglobinuria (HP:0002913) | 1.78400405 |
| 137 | Tibial bowing (HP:0002982) | 1.78015640 |
| 138 | Hyperparathyroidism (HP:0000843) | 1.77877724 |
| 139 | Muscle fiber splitting (HP:0003555) | 1.77809587 |
| 140 | Bone cyst (HP:0012062) | 1.76952665 |
| 141 | Congenital, generalized hypertrichosis (HP:0004540) | 1.76566753 |
| 142 | Torticollis (HP:0000473) | 1.76188342 |
| 143 | Choanal stenosis (HP:0000452) | 1.76100949 |
| 144 | Prominent supraorbital ridges (HP:0000336) | 1.75257433 |
| 145 | Synostosis of carpal bones (HP:0005048) | 1.75009783 |
| 146 | Neoplasm of the heart (HP:0100544) | 1.74858853 |
| 147 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.73664504 |
| 148 | Absent toe (HP:0010760) | 1.73647167 |
| 149 | Accelerated skeletal maturation (HP:0005616) | 1.73567697 |
| 150 | Narrow nasal bridge (HP:0000446) | 1.73528032 |
| 151 | Short nail (HP:0001799) | 1.73473040 |
| 152 | Hyporeflexia of lower limbs (HP:0002600) | 1.73083458 |
| 153 | Bowel diverticulosis (HP:0005222) | 1.72471029 |
| 154 | Palmoplantar hyperkeratosis (HP:0000972) | 1.72273100 |
| 155 | Abnormality of permanent molar morphology (HP:0011071) | 1.71502258 |
| 156 | Abnormality of the dental root (HP:0006486) | 1.71502258 |
| 157 | Taurodontia (HP:0000679) | 1.71502258 |
| 158 | Venous abnormality (HP:0002624) | 1.70856812 |
| 159 | Peritonitis (HP:0002586) | 1.70610243 |
| 160 | Hypoplasia of the iris (HP:0007676) | 1.70262870 |
| 161 | Central scotoma (HP:0000603) | 1.69725398 |
| 162 | Hypoplastic heart (HP:0001961) | 1.68692525 |
| 163 | Severe Myopia (HP:0011003) | 1.68495290 |
| 164 | Hyperextensible skin (HP:0000974) | 1.67888936 |
| 165 | Limited hip movement (HP:0008800) | 1.67866552 |
| 166 | Aneurysm (HP:0002617) | 1.67596095 |
| 167 | Down-sloping shoulders (HP:0200021) | 1.67299479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB2 | 4.43503375 |
| 2 | SIK1 | 3.79985673 |
| 3 | MAPK15 | 3.79146480 |
| 4 | MST1R | 3.20530103 |
| 5 | CAMK1D | 2.90189099 |
| 6 | KSR1 | 2.68974471 |
| 7 | TRIB3 | 2.61472055 |
| 8 | LATS1 | 2.44298184 |
| 9 | FGFR2 | 2.38733652 |
| 10 | CAMK1G | 2.18176159 |
| 11 | MAP3K2 | 2.04281906 |
| 12 | LMTK2 | 2.01345602 |
| 13 | SIK3 | 2.00311630 |
| 14 | MAPK12 | 1.84019844 |
| 15 | MAPK7 | 1.75087903 |
| 16 | KIT | 1.71275629 |
| 17 | MARK1 | 1.70719238 |
| 18 | TIE1 | 1.70264663 |
| 19 | DDR2 | 1.62571270 |
| 20 | DMPK | 1.62080745 |
| 21 | PDK3 | 1.61838853 |
| 22 | PDK4 | 1.61838853 |
| 23 | PNCK | 1.61826835 |
| 24 | PDGFRB | 1.57419687 |
| 25 | LATS2 | 1.55414402 |
| 26 | ARAF | 1.49746547 |
| 27 | DAPK2 | 1.46647750 |
| 28 | MAP2K1 | 1.44180919 |
| 29 | CASK | 1.42221842 |
| 30 | NTRK3 | 1.41933634 |
| 31 | PDGFRA | 1.39468931 |
| 32 | FER | 1.38804553 |
| 33 | NTRK2 | 1.37298625 |
| 34 | BCKDK | 1.36932038 |
| 35 | ABL2 | 1.36881342 |
| 36 | KSR2 | 1.33941083 |
| 37 | BCR | 1.29801052 |
| 38 | MUSK | 1.29678766 |
| 39 | MET | 1.22855339 |
| 40 | CDK8 | 1.20726822 |
| 41 | EPHA4 | 1.11606891 |
| 42 | PDK2 | 1.07938313 |
| 43 | FGFR1 | 1.07606723 |
| 44 | MAP3K10 | 1.07516022 |
| 45 | PRKD3 | 1.02095238 |
| 46 | DAPK3 | 1.02005277 |
| 47 | MAPKAPK3 | 1.01714674 |
| 48 | ILK | 1.01478421 |
| 49 | MAPK4 | 1.01409442 |
| 50 | UHMK1 | 0.98861432 |
| 51 | ROCK2 | 0.97036725 |
| 52 | PAK2 | 0.96568610 |
| 53 | RIPK1 | 0.95957120 |
| 54 | PRKAA2 | 0.91417436 |
| 55 | STK39 | 0.90192755 |
| 56 | NTRK1 | 0.89624221 |
| 57 | ROCK1 | 0.88797816 |
| 58 | TAF1 | 0.84916685 |
| 59 | PRKG1 | 0.84644657 |
| 60 | PRKG2 | 0.83644135 |
| 61 | RAF1 | 0.83442506 |
| 62 | TESK1 | 0.83249784 |
| 63 | ERBB2 | 0.81871227 |
| 64 | CDK9 | 0.81439795 |
| 65 | CAMK2B | 0.79778182 |
| 66 | CDK3 | 0.79315776 |
| 67 | TTN | 0.76354993 |
| 68 | CDC42BPA | 0.76353076 |
| 69 | STK38 | 0.75242975 |
| 70 | GRK1 | 0.74471870 |
| 71 | MOS | 0.73800188 |
| 72 | CAMK2G | 0.73385931 |
| 73 | CAMKK1 | 0.72883112 |
| 74 | PINK1 | 0.71873111 |
| 75 | TYRO3 | 0.71639480 |
| 76 | MYLK | 0.70829412 |
| 77 | MAP3K9 | 0.70342275 |
| 78 | CDK12 | 0.69920309 |
| 79 | PAK3 | 0.69633490 |
| 80 | CAMK2A | 0.68698728 |
| 81 | TGFBR2 | 0.67083368 |
| 82 | PAK6 | 0.66855715 |
| 83 | TGFBR1 | 0.66851024 |
| 84 | STK38L | 0.66758405 |
| 85 | PKN1 | 0.66276779 |
| 86 | LRRK2 | 0.65648278 |
| 87 | INSRR | 0.65239581 |
| 88 | MAP3K12 | 0.65019571 |
| 89 | PTK2B | 0.62951176 |
| 90 | MAP3K3 | 0.62895512 |
| 91 | MARK2 | 0.61316973 |
| 92 | PHKG1 | 0.60854675 |
| 93 | PHKG2 | 0.60854675 |
| 94 | MAPKAPK5 | 0.60590032 |
| 95 | EEF2K | 0.60302893 |
| 96 | RIPK4 | 0.59504198 |
| 97 | PRKCE | 0.59448512 |
| 98 | PRKCG | 0.58283632 |
| 99 | MAP2K2 | 0.58254228 |
| 100 | PRPF4B | 0.56648675 |
| 101 | BMX | 0.56364547 |
| 102 | EPHA3 | 0.55454024 |
| 103 | ERBB4 | 0.55439641 |
| 104 | PIK3CA | 0.54699198 |
| 105 | ERN1 | 0.53914739 |
| 106 | RET | 0.52732488 |
| 107 | MAP3K1 | 0.51793918 |
| 108 | CDK15 | 0.51559703 |
| 109 | MAP2K4 | 0.51499936 |
| 110 | MINK1 | 0.51464983 |
| 111 | STK24 | 0.50831903 |
| 112 | SRC | 0.49656100 |
| 113 | IRAK1 | 0.48254506 |
| 114 | MAPK10 | 0.47563473 |
| 115 | PLK2 | 0.47378268 |
| 116 | RPS6KA2 | 0.47174662 |
| 117 | STK11 | 0.46972005 |
| 118 | CDK18 | 0.45540990 |
| 119 | CDK11A | 0.45497430 |
| 120 | CDK6 | 0.45059653 |
| 121 | PRKD1 | 0.44821426 |
| 122 | GSK3A | 0.44793004 |
| 123 | CAMK1 | 0.43983487 |
| 124 | MAP3K4 | 0.42457976 |
| 125 | BMPR1B | 0.41730217 |
| 126 | IGF1R | 0.41632900 |
| 127 | PIK3CG | 0.40915505 |
| 128 | PTK2 | 0.40904624 |
| 129 | PIM2 | 0.40801967 |
| 130 | IRAK2 | 0.39637170 |
| 131 | DYRK1A | 0.39309678 |
| 132 | CDK19 | 0.39001083 |
| 133 | FGFR3 | 0.38766581 |
| 134 | AKT2 | 0.38506968 |
| 135 | NEK9 | 0.38304237 |
| 136 | MAP3K13 | 0.36824097 |
| 137 | SGK223 | 0.36601129 |
| 138 | EPHB1 | 0.36076031 |
| 139 | MAP3K6 | 0.35648844 |
| 140 | INSR | 0.35590279 |
| 141 | ADRBK1 | 0.34365948 |
| 142 | CDK5 | 0.33635516 |
| 143 | GRK5 | 0.33569823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.11420767 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.10347864 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.97191845 |
| 4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.71049923 |
| 5 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.71009614 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.43498315 |
| 7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.41439464 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.34487227 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31027278 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09375016 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 2.03224107 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.97410052 |
| 13 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.82916293 |
| 14 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.62288816 |
| 15 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.53281317 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.50241366 |
| 17 | Melanogenesis_Homo sapiens_hsa04916 | 1.49829444 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.48094901 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.47438710 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42836017 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38289466 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.34932792 |
| 23 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.30288128 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.28609921 |
| 25 | Axon guidance_Homo sapiens_hsa04360 | 1.27421325 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.27401982 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26557572 |
| 28 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.26199619 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25896458 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.22560356 |
| 31 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.21823648 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.21676029 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.20804125 |
| 34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.19786053 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.18164713 |
| 36 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.18160607 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.13928347 |
| 38 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.11422956 |
| 39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.09000641 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08215778 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06446697 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05967619 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03952137 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02791290 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02466404 |
| 46 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02276956 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00625043 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00264724 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 1.00098615 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97347994 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.96641711 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.95034517 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94902119 |
| 54 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.94240049 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93516750 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93447115 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93227284 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91857032 |
| 59 | Salivary secretion_Homo sapiens_hsa04970 | 0.91155067 |
| 60 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89739729 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89601231 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86944972 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86636609 |
| 64 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.86509773 |
| 65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86271857 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83142059 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82754832 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.82129635 |
| 69 | Melanoma_Homo sapiens_hsa05218 | 0.80991665 |
| 70 | Pathways in cancer_Homo sapiens_hsa05200 | 0.80183264 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79428139 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79115962 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78591832 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77262029 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76878694 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.75756158 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.74898350 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74291705 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73561467 |
| 80 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.73231231 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73094567 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72471761 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69289453 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68522204 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67348747 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66789728 |
| 87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64630307 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64245389 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62830052 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62754717 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62326202 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.62255023 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61826583 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61657943 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61598485 |
| 96 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.60860649 |
| 97 | Gap junction_Homo sapiens_hsa04540 | 0.60858341 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60033958 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.59360586 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59345230 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.58748215 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58065991 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56696671 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56504071 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55721602 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.55152236 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54632139 |
| 108 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52775511 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52705010 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51968397 |
| 111 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.51424846 |
| 112 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51382097 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50409093 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48771313 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48313539 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.47657901 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47353062 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47335851 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47296526 |
| 120 | Phototransduction_Homo sapiens_hsa04744 | 0.46979516 |
| 121 | Long-term depression_Homo sapiens_hsa04730 | 0.46310067 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45878148 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | 0.45368200 |
| 124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43851300 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43601624 |
| 126 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43060791 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42891940 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42154770 |
| 129 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41468316 |
| 130 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41031532 |
| 131 | GABAergic synapse_Homo sapiens_hsa04727 | 0.40096188 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39601200 |
| 133 | Prion diseases_Homo sapiens_hsa05020 | 0.38672141 |
| 134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37884484 |

